FindTrial
Sign In

A clinical trial to study the effects of drugs i.e. intravenous nalbuphine and dexmedetomidine as premedication on emergence agitation in adult patients undergoing abdominal surgery.

Comparison of effect of intravenous nalbuphine and dexmedetomidine as premedication on emergence agitation in adult patients undergoing abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029347
Enrollment
80
Registered
2020-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F05- Delirium due to known physiological condition

Interventions

Intervention1: Dexmedetomidine: Injection dexmedetomidine given intravenously 15 minutes before surgery. Control Intervention1: Nalbuphine: Injection Nalbuphine given intravenously 15 minutes before s

Sponsors

GGS Medical College and Hospital Faridkot Punjab
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age between 18 to 55 years, undergoing abdominal surgery under General anaesthesia (GA). 2. ASA I & II.

Exclusion criteria

Exclusion criteria: 1. Duration of surgery 2. Patient having renal, hepatic, cardiovascular and cerebral dysfunction. 3. History of anaphylaxis or allergy to the study drugs 4. BM I >30 kg/m2. 5. Psychiatric disorders or drug abuse. • Patients refused to participate in study.

Design outcomes

Primary

MeasureTime frame
To compare the effect of IV nalbuphine and dexmedetomidine on incidence of EA.Timepoint: Hourly monitoring till 12 hours.—

Secondary

MeasureTime frame
1. Severity of EA. 2. NRS score for Post Operative Pain (POP) assessment. 3. Hemodynamic variability. 4. Post operative total analgesic requirement. 5. Patientâ??s satisfaction. 6. Side effects if any. Timepoint: Hourly monitoring till 12 hours.—

Countries

India

Contacts

Public ContactDr Sarvjeet Kaur

G.G.S. Medical College and Hospital, Faridkot.

drsarvjeetk@gmail.com9915680508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026